Home Medical Devices Neurology Clinical Trials Market Size, Share & Drivers, 2033

Neurology Clinical Trials Market Size & Outlook, 2025-2033

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRMD2946DR
Last Updated : May, 2025
Pages : 110
Author : Jay Mehta
Format : PDF, Excel

Market Segmentation

  1. Neurology Clinical Trials Market, By Phase (2021-2033)
    1. Phase I
    2. Phase II
    3. Phase III
    4. Phase IV
  2. Neurology Clinical Trials Market, By Study Design (2021-2033)
    1. Interventional
    2. Observational
    3. Expanded Access
  3. Neurology Clinical Trials Market, By Indication (2021-2033)
    1. Epilepsy
    2. Parkinson's Disease (PD)
    3. Huntington's Disease
    4. Stroke
    5. Traumatic Brain Injury (TBI)
    6. Amyotrophic Lateral Sclerosis (ALS)
    7. Muscle regeneration
    8. Others
    1. North America
      1. North America Neurology Clinical Trials Market, By Phase
        1. Phase I
          1. Phase II
            1. Phase III
              1. Phase IV
              2. North America Neurology Clinical Trials Market, By Study Design
                1. Interventional
                  1. Observational
                    1. Expanded Access
                    2. North America Neurology Clinical Trials Market, By Indication
                      1. Epilepsy
                        1. Parkinson's Disease (PD)
                          1. Huntington's Disease
                            1. Stroke
                              1. Traumatic Brain Injury (TBI)
                                1. Amyotrophic Lateral Sclerosis (ALS)
                                  1. Muscle regeneration
                                    1. Others
                                    2. U.S.
                                      1. U.S. Neurology Clinical Trials Market, By Phase
                                        1. Phase I
                                          1. Phase II
                                            1. Phase III
                                              1. Phase IV
                                              2. U.S. Neurology Clinical Trials Market, By Study Design
                                                1. Interventional
                                                  1. Observational
                                                    1. Expanded Access
                                                    2. U.S. Neurology Clinical Trials Market, By Indication
                                                      1. Epilepsy
                                                        1. Parkinson's Disease (PD)
                                                          1. Huntington's Disease
                                                            1. Stroke
                                                              1. Traumatic Brain Injury (TBI)
                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                  1. Muscle regeneration
                                                                    1. Others
                                                                  2. Canada
                                                                2. Europe
                                                                  1. Europe Neurology Clinical Trials Market, By Phase
                                                                    1. Phase I
                                                                      1. Phase II
                                                                        1. Phase III
                                                                          1. Phase IV
                                                                          2. Europe Neurology Clinical Trials Market, By Study Design
                                                                            1. Interventional
                                                                              1. Observational
                                                                                1. Expanded Access
                                                                                2. Europe Neurology Clinical Trials Market, By Indication
                                                                                  1. Epilepsy
                                                                                    1. Parkinson's Disease (PD)
                                                                                      1. Huntington's Disease
                                                                                        1. Stroke
                                                                                          1. Traumatic Brain Injury (TBI)
                                                                                            1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                              1. Muscle regeneration
                                                                                                1. Others
                                                                                                2. U.K.
                                                                                                  1. U.K. Neurology Clinical Trials Market, By Phase
                                                                                                    1. Phase I
                                                                                                      1. Phase II
                                                                                                        1. Phase III
                                                                                                          1. Phase IV
                                                                                                          2. U.K. Neurology Clinical Trials Market, By Study Design
                                                                                                            1. Interventional
                                                                                                              1. Observational
                                                                                                                1. Expanded Access
                                                                                                                2. U.K. Neurology Clinical Trials Market, By Indication
                                                                                                                  1. Epilepsy
                                                                                                                    1. Parkinson's Disease (PD)
                                                                                                                      1. Huntington's Disease
                                                                                                                        1. Stroke
                                                                                                                          1. Traumatic Brain Injury (TBI)
                                                                                                                            1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                              1. Muscle regeneration
                                                                                                                                1. Others
                                                                                                                              2. Germany
                                                                                                                              3. France
                                                                                                                              4. Spain
                                                                                                                              5. Italy
                                                                                                                              6. Russia
                                                                                                                              7. Nordic
                                                                                                                              8. Benelux
                                                                                                                              9. Rest of Europe
                                                                                                                            2. APAC
                                                                                                                              1. APAC Neurology Clinical Trials Market, By Phase
                                                                                                                                1. Phase I
                                                                                                                                  1. Phase II
                                                                                                                                    1. Phase III
                                                                                                                                      1. Phase IV
                                                                                                                                      2. APAC Neurology Clinical Trials Market, By Study Design
                                                                                                                                        1. Interventional
                                                                                                                                          1. Observational
                                                                                                                                            1. Expanded Access
                                                                                                                                            2. APAC Neurology Clinical Trials Market, By Indication
                                                                                                                                              1. Epilepsy
                                                                                                                                                1. Parkinson's Disease (PD)
                                                                                                                                                  1. Huntington's Disease
                                                                                                                                                    1. Stroke
                                                                                                                                                      1. Traumatic Brain Injury (TBI)
                                                                                                                                                        1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                          1. Muscle regeneration
                                                                                                                                                            1. Others
                                                                                                                                                            2. China
                                                                                                                                                              1. China Neurology Clinical Trials Market, By Phase
                                                                                                                                                                1. Phase I
                                                                                                                                                                  1. Phase II
                                                                                                                                                                    1. Phase III
                                                                                                                                                                      1. Phase IV
                                                                                                                                                                      2. China Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                        1. Interventional
                                                                                                                                                                          1. Observational
                                                                                                                                                                            1. Expanded Access
                                                                                                                                                                            2. China Neurology Clinical Trials Market, By Indication
                                                                                                                                                                              1. Epilepsy
                                                                                                                                                                                1. Parkinson's Disease (PD)
                                                                                                                                                                                  1. Huntington's Disease
                                                                                                                                                                                    1. Stroke
                                                                                                                                                                                      1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                        1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                          1. Muscle regeneration
                                                                                                                                                                                            1. Others
                                                                                                                                                                                          2. Korea
                                                                                                                                                                                          3. Japan
                                                                                                                                                                                          4. India
                                                                                                                                                                                          5. Australia
                                                                                                                                                                                          6. Taiwan
                                                                                                                                                                                          7. South East Asia
                                                                                                                                                                                          8. Rest of Asia-Pacific
                                                                                                                                                                                        2. Middle East and Africa
                                                                                                                                                                                          1. Middle East and Africa Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                            1. Phase I
                                                                                                                                                                                              1. Phase II
                                                                                                                                                                                                1. Phase III
                                                                                                                                                                                                  1. Phase IV
                                                                                                                                                                                                  2. Middle East and Africa Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                    1. Interventional
                                                                                                                                                                                                      1. Observational
                                                                                                                                                                                                        1. Expanded Access
                                                                                                                                                                                                        2. Middle East and Africa Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                          1. Epilepsy
                                                                                                                                                                                                            1. Parkinson's Disease (PD)
                                                                                                                                                                                                              1. Huntington's Disease
                                                                                                                                                                                                                1. Stroke
                                                                                                                                                                                                                  1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                    1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                      1. Muscle regeneration
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. UAE
                                                                                                                                                                                                                          1. UAE Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                            1. Phase I
                                                                                                                                                                                                                              1. Phase II
                                                                                                                                                                                                                                1. Phase III
                                                                                                                                                                                                                                  1. Phase IV
                                                                                                                                                                                                                                  2. UAE Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                    1. Interventional
                                                                                                                                                                                                                                      1. Observational
                                                                                                                                                                                                                                        1. Expanded Access
                                                                                                                                                                                                                                        2. UAE Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                          1. Epilepsy
                                                                                                                                                                                                                                            1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                              1. Huntington's Disease
                                                                                                                                                                                                                                                1. Stroke
                                                                                                                                                                                                                                                  1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                    1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                      1. Muscle regeneration
                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                      1. LATAM Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                                                        1. Phase I
                                                                                                                                                                                                                                                          1. Phase II
                                                                                                                                                                                                                                                            1. Phase III
                                                                                                                                                                                                                                                              1. Phase IV
                                                                                                                                                                                                                                                              2. LATAM Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                                                1. Interventional
                                                                                                                                                                                                                                                                  1. Observational
                                                                                                                                                                                                                                                                    1. Expanded Access
                                                                                                                                                                                                                                                                    2. LATAM Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                                                      1. Epilepsy
                                                                                                                                                                                                                                                                        1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                                                          1. Huntington's Disease
                                                                                                                                                                                                                                                                            1. Stroke
                                                                                                                                                                                                                                                                              1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                                                  1. Muscle regeneration
                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                    2. Brazil
                                                                                                                                                                                                                                                                                      1. Brazil Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                                                                                        1. Phase I
                                                                                                                                                                                                                                                                                          1. Phase II
                                                                                                                                                                                                                                                                                            1. Phase III
                                                                                                                                                                                                                                                                                              1. Phase IV
                                                                                                                                                                                                                                                                                              2. Brazil Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                                                                                1. Interventional
                                                                                                                                                                                                                                                                                                  1. Observational
                                                                                                                                                                                                                                                                                                    1. Expanded Access
                                                                                                                                                                                                                                                                                                    2. Brazil Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                                                                                      1. Epilepsy
                                                                                                                                                                                                                                                                                                        1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                                                                                          1. Huntington's Disease
                                                                                                                                                                                                                                                                                                            1. Stroke
                                                                                                                                                                                                                                                                                                              1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                                                                                  1. Muscle regeneration
                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                                                                                                              Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                                              Get This Report

                                                                                                                                                                                                                                                                                                              Download Free Sample

                                                                                                                                                                                                                                                                                                              Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                                              The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                                              Our Clients:

                                                                                                                                                                                                                                                                                                              LG Electronics
                                                                                                                                                                                                                                                                                                              AMCAD Engineering
                                                                                                                                                                                                                                                                                                              KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                              Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                              Voith Group
                                                                                                                                                                                                                                                                                                              International Paper
                                                                                                                                                                                                                                                                                                              Hansol Paper
                                                                                                                                                                                                                                                                                                              Whirlpool Corporation
                                                                                                                                                                                                                                                                                                              Sony
                                                                                                                                                                                                                                                                                                              Samsung Electronics
                                                                                                                                                                                                                                                                                                              Qualcomm
                                                                                                                                                                                                                                                                                                              Google
                                                                                                                                                                                                                                                                                                              Fiserv
                                                                                                                                                                                                                                                                                                              Veto-Pharma
                                                                                                                                                                                                                                                                                                              Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                              Merck
                                                                                                                                                                                                                                                                                                              Argon Medical Devices
                                                                                                                                                                                                                                                                                                              Abbott
                                                                                                                                                                                                                                                                                                              Ajinomoto
                                                                                                                                                                                                                                                                                                              Denon
                                                                                                                                                                                                                                                                                                              Doosan
                                                                                                                                                                                                                                                                                                              Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                              LG Chemicals
                                                                                                                                                                                                                                                                                                              LCY chemical group
                                                                                                                                                                                                                                                                                                              Bayer
                                                                                                                                                                                                                                                                                                              Airrane
                                                                                                                                                                                                                                                                                                              BASF
                                                                                                                                                                                                                                                                                                              Toyota Industries
                                                                                                                                                                                                                                                                                                              Nissan Motors
                                                                                                                                                                                                                                                                                                              Neenah
                                                                                                                                                                                                                                                                                                              Mitsubishi
                                                                                                                                                                                                                                                                                                              Hyundai Motor Company

                                                                                                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                                                                                                              Address:
                                                                                                                                                                                                                                                                                                              Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                                              Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                                              Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                                              Contact Us:
                                                                                                                                                                                                                                                                                                              +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                              +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                              +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                              sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                              Quick Links
                                                                                                                                                                                                                                                                                                              Help
                                                                                                                                                                                                                                                                                                              Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                              DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                              Secure Payments:
                                                                                                                                                                                                                                                                                                              Follow Us:
                                                                                                                                                                                                                                                                                                              www.straitsresearch.com © Copyright . All rights Reserved.